deltatrials
Completed NCT07114276

Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients

Sponsor: Taipei Medical University

Conditions Acute Kidney Disease Acute Kidney Injury Chemotherapy Side Effects Machine Learning
Interventions Machine learning models predictions of acute kidney injury and acute kidney disease
Updated 2 times since 2025 Last updated: Jan 7, 2026 Started: Oct 30, 2023 Primary completion: Nov 30, 2025 Completion: Nov 30, 2025

A observational or N/A phase clinical study on Acute Kidney Disease and Acute Kidney Injury, this trial is completed. The trial is conducted by Taipei Medical University and has accumulated 2 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

2 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed

    Status: Recruiting → Completed

  2. Sep 2025 — Feb 2026 [monthly]

    Recruiting

    First recorded

Oct 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Taipei Medical University
  • Taipei Medical University WanFang Hospital
Data source: Taipei Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Taipei, Taiwan